Log In
Print
BCIQ
Print
Print this Print this
 

Somatoprim (COR-005, DG3173)

  Manage Alerts
Collapse Summary General Information
Company Cortendo AB
DescriptionSomatostatin analog that suppresses human growth hormone (hGH) secretion by targeting somatostatin receptors 2, 4 and 5
Molecular Target Somatostatin receptor 2 (SSTR2) ; Somatostatin receptor 4 (SSTR4)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAcromegaly
Indication DetailsTreat acromegaly
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$30.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today